| ［1］ |
Gudas L J.Retinoids， retinoid-responsive genes， cell differentiation， and cancer.Cell Growth Differ，1992，3：655 -662.
|
| ［2］ |
Evans R M.The steroid and thyroid hormone receptor superfamily.Science，1988，240：889 -895.
|
| ［3］ |
Eck K M，Yuan L， Duffy L，et al.A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells.Br J Cancer，1998，77：2129 -2137.
|
| ［4］ |
Van heusden J， Wouters W， Ramaekers F C，et al .All-transretinoic acid metabolites significantly inhibit the proliferation of MCF-7 human breast cancer cells in vitro.Br J Cancer，1998，77：26 -32.
|
| ［5］ |
Seewaldt V L， Caldwell L E， Johnson B S，et al.Inhibition of retinoic acid receptor function in normal human mammary epithelial cells results in increased cellular proliferation and inhibits the formation of a polarized epithelium in vitro.Exp Cell Res，1997，236：16 -28.
|
| ［6］ |
Fitzgerald P， Teng M，Chandraratna R A，et al.Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.Cancer Res，1997，57：2642-2650.
|
| ［7］ |
Sheikh M S， Shao Z M， Li X S， et al .Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids.J Biol Chem，1994，269：21 440 -2 1 4 4 7.
|
| ［8］ |
Swisshelm K， Ryan K， Lee X，et al.Down-regulation of retinoic acid receptor beta in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells.Cell Growth Differ，1994，5：133 -141.
|
| ［9］ |
Zhang X K， Liu Y， Lee M 0.Retinoid receptors in lung cancer and breast cancer.Mutat Res，1996，350：267 -277.
|
| ［10］ |
Liu Y， Lee M 0，Wang H G，et al.Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells.Mol Cell Biol，1996，16：1138 -1149.
|
| ［11］ |
Li Y， Hashimoto Y， Agadir A，et al .Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acidinduced apoptosis in human breast cancer cells.J Biol Chem，1999，274：15 360 -15 366.
|
| ［12］ |
Seewaldt V L， Johnson B S， Parker M B，et al.Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells.Cell Growth Differ，1995，6：1077 -1088.
|
| ［13］ |
Shang Y， Baumrucker C R， Green M H.Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells.J Biol Chem，1999，274：18 005 -18 010.
|
| ［14］ |
Hayashi K， Goodison S， Urquidi V，et al.Differential effects of retinoic acid on the growth of isogenic metastatic and nonmetastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.Int J Oncol，2003，22：623 -639.
|
| ［15］ |
Siwak D R， Mendoza Gamboa E， Tari A M.HER-2/neu uses Akt to suppress retinoic acid response element binding activity in MDA-MB-453 breast cancer cells.Int J Oncol，2003，23：1739 - 1745.
|
| ［16］ |
Tari A M， Lim S J， Hung M C， et al.HER-2/neu induces all-trans retinoic acid （ ATRA） resistance in breast cancer cells.Oncogene，2002，21：5224 -5232.
|
| ［17］ |
Lim S J， Gutierrez Puente Y， Tari A M.N-（4-hydroxyphenyl）-retinamide selectively increases All-TRANS retinoic acid inhibitory effects in HER-2/neu-overexpressing breast cancer cells.Tumour Biol，2002，23：279 -286.
|
| ［18］ |
Chen T K， Smith L M， Gebhardt D K， et al.Activation and inhibition of the AP-1 complex in human breast cancer cells.Mol Carcinog，1996，15：215 -226.
|
| ［19］ |
van der Burg B， Slager Davidov R， van der Leede B M，et al .Differential regulation of API activity by retinoic acid in hormone-dependent and -independent breast cancer cells.Mol Cell Endocrinol，1995，112：143 -152.
|
| ［20］ |
Zhou X F， Shen X Q， Shemshedini L.Ligandactivated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization.Mol Endocrinol，1999，13：276 -285.
|
| ［21］ |
Strange K S， Wilkinson D， Emerman J T.Mitogenic properties of insulin-like growth factors Ⅰ and Ⅱ， insulin-like growth factor binding protein-3 and epidermal growth factor on human breast epithelial cells in primary culture.Breast Cancer Res Treat，2002，75：203 -212.
|
| ［22］ |
Krajcik R A， Borofsky N D， Massardo S， et al.Insulin-like growth factor Ⅰ（IGF-I ） ， IGF-binding proteins and breast cancer.Cancer Epidemiol Biomarkers Prev，2002，11：1566 -1 5 7 3 .
|
| ［23］ |
Moschos S J， Mantzoros C S.The role of the IGF system in cancer：from basic to clinical studies and clinical applications.Oncology，2002，63：317 -332.
|
| ［24］ |
Fontana J A， Burrows Mezu A， Clemmons D R， et al .Retinoid modulation of insulin-like growth factor binding proteins and inhibition of breast carcinoma proliferation.Endocrinology，1991，128：1115 -1122.
|
| ［25］ |
Favoni R E， de Cupis A， Bruno S， et al.Modulation of the insulin-like growth factor-Ⅰ system by N-（4-hydroxyphenyl）-retinamide in human breast cancer cell lines.Br J Cancer，1998，77：2138 -2147.
|
| ［26］ |
Torrisi R， Parodi S， Pensa F， et al .Effect of fenretinide on plasma IGF-I and IGFBP-3 in early breast cancer patients.Int J Cancer，1998，76：787 -790.
|
| ［27］ |
Schedlich L J， O'Han M K， Leong G M， et al.Insulin-like growth factor binding protein-3 prevents retinoid receptor heterodimerization：implications for retinoic acid-sensitivity in human breast cancer cells.Biochem Biophys Res Commun，2004，314：83 -88.
|
| ［28］ |
Yang L， Ostrowski J， Reczek P， et al.The retinoic acid receptor antagonist， BMS453， inhibits normal breast cell growth by inducing active TGF beta and causing cell cycle arrest.Oncogene，2001，20：8025 -8035.
|
| ［29］ |
Toma S， Raffo P， Nicolo G， et al.Biological activity of alltrans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients.Int J Oncol，2000，17：991 -1000.
|
| ［30］ |
Herbert B S， Sanders B G， Kline K.N-（4-hydroxyphenyl）retinamide activation of transforming growth factor-beta and induction of apoptosis in human breast cancer cells.Nutr Cancer，1999，34：121 -132.
|
| ［31］ |
Roberson K M， Penland S N， Padilla G M， et al .Fenretinide：induction ofapoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.Cell Growth Differ，1997，8：101 -111.
|
| ［32］ |
Derynck R， Akhurst R J， Balmain A.TGF-beta signaling in tumor suppression and cancer progression.Nat Genet，2001，29：117 -129.
|
| ［33］ |
Teicher B A.Malignant cells， directors of the malignant process：role of transforming growth factor-beta.Cancer Metastasis Rev，2001，20：133 -143.
|
| ［34］ |
Reveneau S， Arnould L， Jolimoy G， et al .Nitric oxide synthase in human breast cancer is associated with tumor grade，proliferation rate and expression of progesterone receptors.Lab Invest，1999，79：1215 -1225.
|
| ［35］ |
Simeone A M， Ekmekcioglu S， Broemeling L D，et al.A novel mechanism by which N-（4-hydroxyphenyl） retinamide inhibits breast cancer cell growth：the production of nitric oxide.Mol Cancer Therap，2002，1：1009 -1017.
|
| ［36］ |
Maurer B J，Melton L， Billups C，et al .Synergistic cytotoxicity in solid tumor cells lines between N-（4-hydroxyphenyl）retinamide and modulators of ceramide metabolism.J Natl Cancer Inst，2000，92：1897 -1909.
|
| ［37］ |
Wang T T， Phang J M.Effect of N-（4-hydroxyphenyl） retinamide on apoptosis in human breast cancer cells.Cancer Lett，1996，107：65 -71.
|
| ［38］ |
DiPietrantonio A M， Hsieh T C， Juan G， et al .Fenretinideinduced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation.Cancer Res，2000，60：4331 -4335.
|
| ［39］ |
Panigone S， Debernardi S， Taya Y，et al.pRb and Cdk regulation by N-（4-hydroxyphenyl） retinamide.Oncogene，2000，19 ：4035 - 4041.
|
| ［40］ |
Teixeira C， Pratt M A C.CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells.Mol Endocrinol，1997，11：1191 -1202.
|
| ［41］ |
Zhou Q， Stetler Stevenson M， Steeg P S.Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.Oncogene，1997，15：107 -115.
|
| ［42］ |
Seewaldt V L， Kim J H， Parker M B，et al.Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.Exp Cell Res，1999，249：70 -85.
|
| ［43］ |
Dietze E C， Caldwell L E， Marcom K， et al .Retinoids and retinoic acid receptors regulate growth arrest and apoptosis in human mammary epithelial cells and modulate expression of CBP/P300.Microsc Res Tech，2002，59：23 -40.
|
| ［44］ |
Sanli U A， Uslu R， Karabulut B，et al.Alterations in the activity and expression of serine/threonine protein phosphatases during all trans retinoic acid-induced apoptosis in breast cancer cells.Oncol Rep，2003，10：2083 -2088.
|
| ［45］ |
Nakagawa S， Fujii T， Yokoyama G，et al .Cell growth inhibition by all-trans retinoic acid in SKBR-3 breast cancer cells：involvement of protein kinase C alpha and extracellular signalregulated kinase mitogen-activated protein kinase.Mol Carcinog，2003，38：106 -116.
|
| ［46］ |
Poot M， Hosier S， Swisshelm K.Distinct patterns of mitochondrial changes precede induction of apoptosis by all-trans-retinoic acid and N-（4-hydroxyphenyl）retinamide in MCF-7 breast cancer cells.Exp Cell Res，2002，279：128 -140.
|
| ［47］ |
Mangiarotti R， Danova M， Alberici R，et al .All-trans retinoic acid （ATRA）-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells.Br J Cancer，1998，77：186 - 191.
|
| ［48］ |
Seewaldt V L， Dietze E C， Johnson B S， et al .Retinoic acidmediated G1 -S-phase arrest of normal human mammary epithelial cells is independent of the level of P53 protein expression.Cell Growth Differ，1999，10：49 -59.
|
| ［49］ |
Baj G， Arnulfo A， Deaglio S，et al.All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression.J Biol Regul Homeost Agents，1999，13：115 -122.
|
| ［50］ |
Shang Y， Baumrucker C R， Green M H.The induction and activation of STAT1 by all-trans-retinoic acid are mediated by RAR beta signaling pathways in breast cancer cells.Oncogene，1999，18：6725 -6732.
|
| ［51］ |
Offterdinger M， Schneider S M， Huber H， et al.Retinoids control the expression of C-erbB receptors in breast cancer cells.Biochem Biophys Res Commun，1998，251（3） ：907 -9 1 3 .
|
| ［52］ |
Sapi E， Flick M B， Tartaro K，et al.Effect of all-trans-retinoic acid on c-fms proto-oncogene ［colony-stimulating factor 1（CSF-1） receptor］expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.Cancer Res，1999，59：5578 -5585.
|
| ［53］ |
Yan W， Li Q， Zhu F.Apoptosis-related genes cloned by improved subtractive hybridization.Chin J Oncol， 2001， 23：193 - 195.
|
| ［54］ |
Ye X， Wu Q， Liu S，et al.Distinct role and functional mode of TR3 and RARalpha in mediating ATRA-induced signalling pathway in breast and gastric cancer cells.Int J Biochem Cell Biol，2004，36：98 -113.
|
| ［55］ |
Wang Q， Lee D， Sysounthone V，et al .1，25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects.Breast Cancer Res Treat，2001，67：157 -168.
|
| ［56］ |
Green S ， Chambon P.Nuclear receptors enhance our understanding of transcriptionregulation.Trends Genet， 1988， 4：309 - 314.
|
| ［57］ |
Koshizuka K， Kubota T， Said J，et al .Combination therapy of a vitamin D3 analog and all-trans-retinoic acid：effect on human breast cancer in nude mice.Anticancer Res， 1999，19（1A） ：519 -524.
|
| ［58］ |
Wang Q， Yang W， Uytingco M S，et al.1，25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.Cancer Res，2000，60：2 0 4 0 - 2 0 4 8.
|
| ［59］ |
Widschwendter M， Daxenbichler G， Bachmair F，et al.Interaction of retinoic acid and interferon-alpha in breast cancer cell lines.Anticancer Res，1996，16：369 -374.
|
| ［60］ |
Widschwendter M， Daxenbichler G，Culig Z，et al.Activity of retinoic acid receptor-gamma selectively binding retinoids alone and in combination with interferon-gamma in breast cancer cell lines.Int J Cancer，1997， 71：497 -504.
|
| ［61］ |
Liu H， Zang C， Fenner M H，et al.PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro.Breast Cancer Res Treat，2003，79：63 -74.
|
| ［62］ |
Elstner E， Williamson E A， Zang C，et al.Novel therapeutic approach：ligands for PPAR gamma and retinoid receptors induce apoptosis in bcl-2 - positive human breast cancer cells.Breast Cancer Res Treat，2002，74：155 -165.
|
| ［63］ |
Elstner E， Muller C， Koshizuka K，et al.Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.Proc Natl Acad Sci U S A，1998，95：8806 -8811.
|
| ［64］ |
Eck Enriquez K， Kiefer T L， Spriggs L L， et al.Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells.Breast Cancer Res Treat，2000，61：229 -239.
|
| ［65］ |
Nowfar S， Teplitzky S R， Melancon K， et al.Tumor preven tion by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin.Breast Cancer Res Treat，2002，72：33 -43.
|
| ［66］ |
韩晓蓉，原莉莉，张毅，等.三苯氧胺联合全反式维甲酸对大鼠乳腺癌的预防作用.第三军医大学学报，2002，23：910 -912.
|
| ［67］ |
Lim S J， Simeone A M， Kim C K， et al.Cyclosporin A enhances the apoptotic effects of N-（4-hydroxyphenyl）retinamide in breast cancer cells.Int J Cancer，2002，101：243 -247.
|
| ［68］ |
Sutton L M， Warmuth M A， Petros W P， et al .Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer：a phase Ⅱ trial.Cancer Chemother Pharmacol，1997，40：335 -341.
|
| ［69］ |
Van heusden J， Wouters W， Ramaekers F C，et al.The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells.Br J Cancer，1998，77：1229 -1235.
|
| ［70］ |
Sporn M B， Dunlop N M， Newton D L， et al.Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs（retinoids）.Fed Proc，1976，35：1332 -1338.
|